Author(s)

Namory Camara¹, Mohamed Tafsir Diallo², Karinka Diawara², Mohamed Lamine Touré^1,2, Bi Joel Cyrille Zamblé², Fodé Abass Cissé^1,2

¹Simbaya Neurology Institute, Conakry, Guinea.
²Department of Neurology of The Ignace Deen University Hospital, Conakry, Guinea.

Introduction: Pain has been defined for more than 20 years by the International Association for the Study of Pain (IASP) as an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. It has been recognized as a feature of Parkinson’s disease (PD) since the first descriptions of the disease. Material and Methods: This was a prospective descriptive study lasting six (06) months from November 1, 2023 to April 30, 2024. We included all patients diagnosed with PD and who had pain. Sociodemographic, clinical, paraclinical and therapeutic data were evaluated for each patient. Results: We identified a sample of 62 Parkinson’s patients, of whom 52 patients or 85.2% had associated pain. We noted a male predominance (38M/14F) and a sex ratio of 2.71. Musculoskeletal pain was common in 80% of our respondents. WHO level I, antidepressants and background treatment for KD were the most prescribed molecules. Conclusion: Our study shows a frequency of pain in PD. However, musculoskeletal pain is the most frequently encountered type of pain in PD patients. WHO step I analgesics, antidepressants and background treatment of KD were the main prescriptions in our study.

Pain, Parkinson’s Disease, Conakry

Camara, N. , Diallo, M. , Diawara, K. , Touré, M. , Zamblé, B. and Cissé, F. (2025) Pain, a Non-Motor Sign Associated with Parkinson’s Disease: The Experience of the Institute of Neurology of Simbaya, Conakry. Advances in Parkinson's Disease, 14, 1-11. doi: 10.4236/apd.2025.141001.